Navigation Links
Ajinomoto Co., Inc. Harnesses Amino Acid Power to Improve Sleep

FORT LEE, N.J., May 31, 2011 /PRNewswire/ -- Ajinomoto Food Ingredients announced that Ajinomoto Co., Inc., a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions, will showcase Glysom™ ( during Sleep 2011, the 25th Annual Meeting of the Associated Professional Sleep Societies to be held in Minneapolis, June 11-15, 2011.

Glysom™ is the latest breakthrough in amino acid and sleep research.  Made from glycine, an amino acid that occurs naturally in the body, Glysom™ is scientifically proven to promote deeper, sounder and more satisfying sleep for occasional sleeplessness without morning drowsiness.* Developed by a team of Ajinomoto Co., Inc. scientists led by Dr. Makoto Bannai, one of the foremost authorities on glycine and its applications to sleep, Glysom™ is particularly effective in promoting the deep, non-REM sleep crucial to feeling refreshed and restored in the morning.*  

"Since not all sleep is created equal, it's not enough to simply increase the number of hours at sleep," said Brendan Naulty, president of Ajinomoto Food Ingredients.  "Glysom™ zeroes in on sleep quality, inducing the healthy deep sleep critical to optimal well-being."

Glycine, the amino acid that is produced naturally in the body and present in many healthy foods such as fish, meat and bean, has been extensively researched.  Dr. Bannai has led glycine research at Ajinomoto Co., Inc. since 2005.  In the past decade, he has authored or co-authored over 20 studies examining various mechanisms of improving sleep and the critical connection between glycine and enhanced sleep quality and daytime performance.   Among Dr. Bannai's key findings are an early appearance of slow wave sleep (SWS) and the reduction of deep (core) body temperature in early phases of sleep after glycine ingestion, all indicators of improved sleep quality.

Introduced in the US in May 2010, Glysom™ is available exclusively through medical professionals.  In the year since its introduction, approximately 70 medical establishments nationwide have begun recommending Glysom™ to patients who experience occasional sleeplessness.  

According to the Centers for Disease Control and Prevention (the CDC), insufficient sleep is a public health epidemic, with an estimated 50-70 million US adults having difficulties with sleep or wakefulness.  

In addition to Glysom™, Ajinomoto Food Ingredients' safe, effective nutraceutical solutions include Capsiate Natura®, a patented, side effect-free dietary supplement with natural capsinoids shown to boost the body's metabolism*; and Natura Guard BP™, a milk protein-derived nutraceutical to help maintain healthy blood pressure levels already within the normal range*.  These products are backed by rigorous clinical studies and are available exclusively through medical professionals.  For more information and a complete list of healthcare professionals that carry Ajinomoto Food Ingredients' nutraceuticals, visit, and

About Ajinomoto Food Ingredients

Ajinomoto Food Ingredients delivers safe, effective ingredients whose functionality has been scientifically proven.  Our mission is the pursuit of better health through better nutrition.  Beginning with AJI-NO-MOTO® MSG, a highly versatile seasoning, our products have diversified to flavor seasonings (bonito, pork, chicken, and beef), sweeteners, savory sauces, enzymes, other food ingredients and nutritional supplements.  Based on the five basic tastes centering on Umami, Ajinomoto supplies ingredients with unique aroma, texture, kokumi (full-bodied taste) and nutritional functionality.  These ingredients make it possible for our customers to build strong brands and offer consumers great-tasting, nutritionally beneficial products.

About Ajinomoto Co., Inc.

Ajinomoto is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals.  For many decades, Ajinomoto has contributed to food culture and human health through wide-ranging application of amino acid technologies.  Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability.  Founded in 1909 and now operating in 23 countries, Ajinomoto had net sales of 1,170.8 billion yen (12.8 billion USD) in fiscal 2010.  For more about Ajinomoto (TYO: 2802), visit

Glysom™ clinical studies are available on request.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Ajinomoto Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ajinomoto Co.s Capsiate Natura® Reaches New Milestone
2. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
3. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
4. Research Team Clones Genes Responsible for Amino Acid Absorption
5. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
6. El Camino Hospital Expands Robotic Surgery Program
7. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
8. Cysview(TM) (Hexaminolevulinate HCl) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer
9. FDA Limits Acetaminophen in Prescription Combination Products; Requires Liver Toxicity Warnings
10. FDA Consumer Health Information - New Steps Aimed at Cutting Risks from Acetaminophen
11. Abuse Deterrent Hydrocodone / Acetaminophen Leads NDA Pipeline
Post Your Comments:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
(Date:6/23/2016)... 2016 The Biotechnology industry might ... present great opportunities to investors. assesses the recent ... (NYSE: XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... receive your complimentary trade alerts at: ...
(Date:6/23/2016)... , June 23, 2016 Leading BioSciences ... address medical conditions resulting from a breakdown of ... appointed Greg Doyle as chief executive ... BioSciences, executive management team and board of directors, ... financial officer. He will provide continued leadership and ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the ... in the world, and the most handsome men, look naturally attractive. Plastic surgery ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):